Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Ireland
  4. Irish Stock Exchange
  5. Malin Corporation plc
  6. News
  7. Summary
    MLC   IE00BVGC3741

MALIN CORPORATION PLC

(MLC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ethypharm Gmbh completed the acquisition of Altan Pharma Limited from Malin Corporation plc and others.

10/01/2021 EST

Ethypharm Gmbh entered into a definitive agreement to acquire Altan Pharma Limited from Malin Corporation plc (ISE:MLC) and others for €100 million on June 18, 2021. The closing of the transaction, which is subject to competition authority filings, is expected during the second half of 2021. Malin latter announced that it had collected €68 million in proceeds from the sale, post-repayment of Altan Pharma's net debt and transaction costs. Malin expects to use the net proceeds received from the sale of Altan, along with cash on hand, to undertake a significant return of capital to shareholders post the close of this transaction. Altan Pharma recorded €41 million in turnover and Net loss of €1 million in 2020. Jefferies International Limited acted as a sole financial advisor to Altan Pharma. Gennat Mouline and Numa Agnan of Eight Advisory acted as financial advisor to the sellers. Willkie Farr & Gallagher LLP acted as legal advisor to Ethypharm. on October 1, 2021.


ę S&P Capital IQ 2021
All news about MALIN CORPORATION PLC
02:51aImmunocore Wins US FDA Nod for Skin Cancer Drug
MT
2021Tranche Update on Malin Corporation plc's Equity Buyback Plan announced on November 23,..
CI
2021Malin Corporation plc's Equity Buyback announced on November 23, 2021, has closed with ..
CI
2021MALIN CORPORATION PLC : Proxy Statments
CO
2021Malin Proposes Tender Offer To Shareholders For Around 22% Of Share Capital
MT
2021Malin Corporation plc announces an Equity Buyback for 9,638,554 shares, representing 22..
CI
2021Malin Corporation plc authorizes a Buyback Plan.
CI
2021MALIN CORPORATION PLC : Crossing thresholds
CO
2021MALIN CORPORATION PLC : Crossing thresholds
CO
2021Ethypharm Gmbh completed the acquisition of Altan Pharma Limited from Malin Corporation..
CI
More news
Analyst Recommendations on MALIN CORPORATION PLC
More recommendations
Financials
Sales 2020 41,0 M 45,7 M 45,7 M
Net income 2020 87,7 M 97,7 M 97,7 M
Net Debt 2020 26,6 M 29,6 M 29,6 M
P/E ratio 2020 2,17x
Yield 2020 -
Capitalization 218 M 243 M 243 M
EV / Sales 2019 6,58x
EV / Sales 2020 5,24x
Nbr of Employees 255
Free-Float 74,3%
Chart MALIN CORPORATION PLC
Duration : Period :
Malin Corporation plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MALIN CORPORATION PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 5,00 €
Average target price 9,17 €
Spread / Average Target 83,3%
Managers and Directors
Darragh Lyons Chief Executive Officer & Executive Director
Pat Jennings Chief Financial Officer
William Francis Daniel Non-Executive Chairman
Ita Finegan Chief Administrator
Jean-Michel Yves Sylvain Cossery Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MALIN CORPORATION PLC0.00%243
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642